Page 31 - Revista científica HMVM ::: Hospital General de Agudos "Magdalena V. de Martínez"

REVISTA CIENTÍFICA HMVM 31

Comentarios Finales:

• Existe hoy en día una alternativa de tra-
tamiento definitivo de la estenosis aortica
en pacientes de alto riesgo, o considerados
inoperables.

• Es necesario una cuidadosa valoración
preoperatoria de las condiciones clínicas,
como así de la anatomía del añillo valvular.

• La decisión sobre la realización de este
procedimiento, surge de la recomendación
de un equipo médico conformado, por clíni-
cos, cirujanos y hemodinamistas.

• Los resultados de la técnica son muy fa-
vorables, con un adecuado éxito periproce-
dimiento y aceptables tasas de mortalidad.

Bibliografía

1. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón- Registry: a European registry of transcatheter aortic
Esquivias G, Baumgartner H,et al. Guidelines on the valve implantation using the Edwards SAPIEN valve.
management of valvular heart disease (version 2012). Circulation. 2010;122:62-9.
EurHeart J. 2012;33:2451-96. 7. Piazza N, Grube E, Gerckens U, Den Heijer P, Linke
A, Luha O, et al. Procedural and 30-day outcomes
2. Bax JJ, Delgado V, Bapat V, Baumgartner H, Collet following transcatheter aortic valve implantation using
JP, Erbel R, et al. Open issues intranscatheter aortic the third generation (18F) CoreValve revalving sys-
valve implantation. Part 1: patient selection and treat- tem: results from the multicentre, expanded evalua-
ment strategy for transcatheter aortic valve implanta- tion registry 1-year following CE mark approval. Euro-
tion. Eur Heart J. 2014;35:2639-54. Intervention.2008;4:242-9.
8. Moat NE, Ludman P, De Belder MA, Bridgewater B,
3. Bax JJ, Delgado V, Bapat V, Baumgartner H, Collet Cunningham AD, Young CP, et al. Long-term out-
JP, Erbel R, et al. Open issues in transcatheter aortic comes after transcatheter aortic valve implantation in
valve implantation. Part 2: procedural issues and out- high-risk patients with severe aortic stenosis: the UK
comes after transcatheter aortic valve implantation. TAVI (United Kingdom Transcatheter Aortic Valve Im-
Eur Heart J. 2014;35:2627-38. plantation) Registry. J Am Coll Cardiol. 2011;58:2130-
8.
4. Dewey TM, Brown D, Ryan WH, Herbert MA, Prince 9. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P,
SL, Mack MJ. Reliability of risk algorithms in predict- Chevreul K, Fajadet J, et al.FRANCE 2 Registry of
ing early and late operative outcomes in high-risk pa- transcatheter aortic-valve implantation in high-risk
tients undergoing aortic valve replacement. J Thorac patients.N Engl J Med. 2012;366:1705-15.
Cardiovasc Surg. 2008;135:180-7. 10. Zahn R, Gerckens U, Grube E, Linke A, Sievert H,
Eggebrecht H, et al. Transcatheter aortic valve im-
5. Sinning JM, Werner N, Nickenig G, Grube E. Trans- plantation: first results from a multi-centre real-world
catheter aortic valve implantation: the evidence. registry. EurHeart J. 2011;32:198-204
Heart. 2012;98 Suppl 4:iv65-72.

6. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre
T, Treede H, et al. Thirty-day results of the SAPIEN
aortic Bioprosthesis European Outcome (SOURCE)

